* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on May 11.
* The Solana Beach California-based company is expected to
report
a 1.5% increase in revenue to $5.105 million from $5.03 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. The company's guidance on March 1 2023,
for the period ended March 31, was for revenue between $5.00
million and $5.50 million.
* Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 18 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18, above its last closing price of $9.35.
This summary was machine generated May 10 at 02:03 GMT. All
figures in US dollars unless otherwise stated